Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reifenberger

Showing results (391-400 of 562) with videos related to

Pageof 57
Sort By:
Clinical Chemistry and Laboratory Medicine|June 9, 2015
Assessing quality and functionality of DNA isolated from FFPE tissues through external quality assessment in tissue banksParviz Ahmad-Nejad, Angelika Duda, Antje Sucker, et al.
Plos One|June 28, 2007
Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumorsJean-Louis Boulay, André R Miserez, Christian Zweifel, et al.
Neuro-Oncology|May 19, 2026
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant GliomasDaniel J Brat, Kenneth Aldape, Pim J French, et al.
Neuro-Oncology|January 30, 2016
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trialBogdana Suchorska, Michael Weller, Ghazaleh Tabatabai, et al.
Acta Neuropathologica|September 2, 2019
FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomasFrank Brand, Alisa Förster, Anne Christians, et al.
Oncogene|November 8, 2011
RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survivalV Goidts, J Bageritz, L Puccio, et al.
Oncogene|August 16, 2006
Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomasR G Weber, A Hoischen, M Ehrler, et al.
Leukemia|November 9, 2007
Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cellM Montesinos-Rongen, A Brunn, S Bentink, et al.
Clinical Neuropathology|May 1, 2020
Quality assurance in neuropathology: Experiences from the round robin trials on <i>IDH</i> mutation and <i>MGMT</i> promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019Markus J Riemenschneider, Josephine Fischer, Maja Grassow-Narlik, et al.
Cancer Research|February 4, 2010
Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cellsAnke Waha, Jörg Felsberg, Wolfgang Hartmann, et al.
Pageof 57

Showing results (391-400 of 562) with videos related to

Sort By:
Pageof 57
Clinical Chemistry and Laboratory Medicine|June 9, 2015
Assessing quality and functionality of DNA isolated from FFPE tissues through external quality assessment in tissue banksParviz Ahmad-Nejad, Angelika Duda, Antje Sucker, et al.
Plos One|June 28, 2007
Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumorsJean-Louis Boulay, André R Miserez, Christian Zweifel, et al.
Neuro-Oncology|May 19, 2026
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant GliomasDaniel J Brat, Kenneth Aldape, Pim J French, et al.
Neuro-Oncology|January 30, 2016
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trialBogdana Suchorska, Michael Weller, Ghazaleh Tabatabai, et al.
Acta Neuropathologica|September 2, 2019
FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomasFrank Brand, Alisa Förster, Anne Christians, et al.
Oncogene|November 8, 2011
RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survivalV Goidts, J Bageritz, L Puccio, et al.
Oncogene|August 16, 2006
Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomasR G Weber, A Hoischen, M Ehrler, et al.
Leukemia|November 9, 2007
Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cellM Montesinos-Rongen, A Brunn, S Bentink, et al.
Clinical Neuropathology|May 1, 2020
Quality assurance in neuropathology: Experiences from the round robin trials on <i>IDH</i> mutation and <i>MGMT</i> promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019Markus J Riemenschneider, Josephine Fischer, Maja Grassow-Narlik, et al.
Cancer Research|February 4, 2010
Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cellsAnke Waha, Jörg Felsberg, Wolfgang Hartmann, et al.
Pageof 57